Filip Szenborn

COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial

K. Ludwikowska, L. Szenborn, M. Ussowicz, 2023, Vaccines.

The COVID-19 mRNA BNT163b2 Vaccine Was Well Tolerated and Highly Immunogenic in Young Adults in Long Follow-Up after Haematopoietic Stem Cell Transplantation

L. Szenborn, M. Ussowicz, J. Owoc-Lempach, 2021, Vaccines.

COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study

K. Ludwikowska, L. Szenborn, M. Kursa, 2023, Vaccine.

COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS)

K. Ludwikowska, L. Szenborn, M. Kursa, 2023, Vaccine.

Upper respiratory tract infections and influenza-like illnesses among healthcare workers: are serological tests useful in monitoring influenza and influenza-like illness?

L. Szenborn, Ernest P Kuchar, Filip Szenborn, 2022, Medycyna pracy.